Is it fair to
describe a protein recruited for
many cellular chores as
‘moonlighting’ and ‘promiscuous’? |
T. Ramasarma
The active site of an enzyme protein occupies a
relatively small area of its large surface. Many more activities can be
accomplished by a single protein provided more active sites can be
fitted on its vast unused (?) surface. This makes sense in the best
interest of the cellular economy. The concept of multifunctionality of
some enzyme proteins is accepted1; never mind the dogma of
their specificity, as the two sites can act independently. It is not
necessary that the same molecule of the protein does one job at a time.
There are many molecules of the protein in the cell, and portions of
these can be assigned for each task in different parts of the cell. The
concept of multiple functions of a protein can be expanded to encompass
non-catalytic structural roles. In order to popularize the phenomenon,
attempts are made to add colloquial adjectives such as moonlighting and
promiscuous. I believe that the use of inappropriate descriptions for
catching the attention of readers is likely to be counterproductive. A
case is made here for caution and restraint.
One protein – many
functions
I had earlier made an attempt to put together some
information available on proteins having more than one function in an
article in Current Science2. The introductory
paragraph and the two concluding paragraphs therein, which define
succinctly this concept, are reproduced below:
‘The concept of one enzyme-one activity has influenced
biochemistry for over half a century. Over 1000 enzymes are now
described. Many of them are highly "specific". Some of them are
crystal-lized and their three-dimensional structures determined. They
range from 12 to 1000 kDa in molecular weight and possess 124 to
several hundreds of amino acids. They occur as single polypeptides or
multiple-subunit proteins. The active sites are assembled on these by
appropriate tertiary folding of the polypeptide chain, or by interaction
of their constituent subunits. The substrate is held by side-chains of a
few amino acids at the active site on the surface, occupying a tiny
fraction of the total area. What is the bulk of the protein behind the
active site doing? Do all proteins have only one function each? Why not
a protein have more than one active site on its large surface? Will we
discover more than one activity for some proteins? These newer
possibilities are emerging and are find-ing experimental support. Some
proteins purified to homogeneity using assay methods for different
activities are now recognized to have the same molecular weight and a
high degree of homology of amino acid sequence. Obviously they are
identical. They represent the phenomenon of one protein – many
functions.
‘Three distinct ways of using a protein become apparent
from the examples available: multiple catalytic sites, binding
properties and structural roles. Thus, a protein active as an enzyme can
be "recruited" to do other functions. It can bind to its own substrate
or other metabolites (e.g. tRNA) and transport them. Complexing with
distinct structures in mRNA or DNA, it can play a regulatory role. The
regulatory elements and transcription factors may turn out to be a known
enzyme protein. It can become a structural element like in lens
crystallins or in the subunit or membrane structures. Indeed, the
possibilities are legion.
‘One other perspective is emerging. How valid is the
enzyme nomenclature in the light of these developments? In the foregoing
examples, it can be seen that a 58 kDa-protein is identified with
at least four distinct catalytic activities, and there are at least two
distinctive 58 kDa-proteins with other activities. It is
Table 1. One protein – many
functions (1p–nf)
Serial
No. |
Primary identity
|
Other activities
|
|
|
|
|
|
|
1 |
Protein disulfide isomerase (58 kDa) |
– Prolyl hydroxylase (a
subunit) – Thyroxine-binding
protein – Peptide-binding (sequence
non-specific) – Oligosaccharyl transferase (a
subunit) – Triglyceride transfer protein (a
subunit) – Thioredoxin-like activity |
|
|
|
2 |
Pyruvate kinase (58 kDa) |
T3-binding protein |
|
|
|
3 |
Lipid-transfer protein (58 kDa) |
Sterol carrier protein 2 |
|
|
|
4 |
Fermodulin (58 kDa, HMGCoA reductase
inhibitor) |
Fe-binding protein (low affinity) |
|
|
|
5 |
Peptidyl-prolyl cis-trans isomerase
(17 kDa) |
– Cyclophilin
– Cyclosporin A-binding protein |
|
|
|
6 |
Glyceraldehyde-3-phosphate dehydrogenase (37 kDa)
(a house keeping enzyme, occurs in large
concentration) |
– Acyl phosphatase
– Esterase
– ADP-ribosylation
– Microtubule-binding protein
– Protein kinase
– Uracil-DNA glycosylase
– t-RNA-binding protein(sequence specific)
– Amyloid protein (Amy c)-binding protein
– Membrane binding protein |
|
|
|
7 |
Lens
crystallins |
|
|
– alpha |
– Chaperone-like activity6 |
|
– delta |
– Arginine-succinate lyase |
|
– epsilon |
– Lactate dehydrogenase B |
|
– eta |
– Aldehyde dehydrogenase |
|
– lambda |
– Hydroxyacyl CoA dehydrogenase |
|
– mu |
– Ornithine cyclodeaminase |
|
– rho |
– NADPH-quinone reductase |
|
– tau |
– Enolase |
|
– sigma |
– GSH-S-transferase |
|
|
|
8 |
Aconitase (with Fe-S cluster, mitochondrial, also in
cytosol) |
Iron-response element (IRE)-binding protein (no Fe
cluster) (coexists in cytosol with active aconitase
form) |
|
|
|
9 |
Isocitrate dehydrogenase |
|
|
– Mitochondrial, NAD-specific |
– Mitochondrial mRNA-binding protein |
|
– Cytosolic, NADP-specific |
– NADH-decavanadate reductase |
|
|
|
10 |
Lactoferrin (Fe-binding, 80 kDa) |
Ribonuclease |
|
|
|
11 |
a -subunit of F1-ATPase
(mitochondrial, 57 kDa) |
Heat-shock protein in peroxisomes |
|
|
|
12 |
Peroxidase (Mn-dependent, N. crassa
protein) |
Heat
shock protein |
|
|
|
13 |
Separate non-overlapping active sites |
|
|
– Pseudomonas syringe protein |
– Oxygenase and dioxygenase |
|
– Mitochondrial signal peptidase |
– Two catalytic subunits of non overlapping
specificities |
|
– Amylase/Trypsin inhibitor |
– Independent inhibition of two
activities |
|
|
|
14 |
Leukocyte antigen CD 38 (46 kDa) |
– NAD-glycohydrolase |
|
|
– ADP-ribose cyclase |
|
|
– Cyclic ADP-ribose hydrolase |
|
|
|
15 |
Put A
proline dehydrogenase(plasma membrane) |
DNA-binding transcriptional repressor in
cytoplasm |
|
|
|
16 |
Phosphoglucose isomerase (cytosolic) |
Neuroleukin, autocrine motility factor, differentiation
and maturity mediator (extracellular) |
|
|
|
17 |
Thymidine phosphorylase (cytosolic) |
Platelet-derived growth factor (PDGF) of endothelial cells
(extracellular) |
|
|
|
18 |
Carbinolamine dehydratase (converts 4a -hydroxy H4- to quinonoid
H2-biopterin) |
Dimerization cofactor (DCoH) of hepatic nuclear
transcription factor (HNF-1a
) |
|
|
|
19 |
Thioredoxin of E. coli |
T7 -DNA polymerase subunit
(heterodimeric) |
|
|
|
20 |
Aspartate receptor of E. coli |
Maltose-binding protein receptor (different binding
site) |
|
|
|
21 |
PMS2
mismatch repair enzyme |
Blood
cell protein for hypermutation of antibody variable
chain |
|
|
|
22 |
Cystic fibrosis transmembrane conductance
channel regulator (CFTR), cAMP-dependent Cl-
channel |
Epithelial sodium channel regulator protein |
|
|
|
23 |
Multidrug resistance transmembrane transporter (MDR
ATPase, p-glycoprotein) |
Cell
swelling ion channel regulator protein |
|
|
|
24 |
Thrombin (protease in blood clotting cascade) |
Ligand for cell surface receptor, PAR-1 (G-protein
coupled) |
|
|
|
25 |
Thymidylate synthetase |
Binding protein of own mRNA, inhibits
translation |
|
|
|
26 |
Biotin-5¢ -adenylate synthetase
(E. coli) |
Repressor protein of Bio operon |
|
|
|
27 |
LON
protease (ATP-dependent) (mitochondrial) |
Mitochondrial chaperone |
|
|
|
28 |
Ftsh
protein (assists protein transport across membranes in
bacteria) |
Metalloprotease (ATP-dependent) |
|
|
|
29 |
Afg
31/Rcalp protein (facilitates assembly of
F0F1-ATPase) |
Protease, degrades improperly folded proteins |
|
|
|
30 |
Band
3 protein (RBC plasma membrane)-anion exchanger |
Glycolysis inhibitor protein (acts by N-terminal domain
binding to aldolase, glyceraldehyde-3-phosphate dehydrogenase and
phosphofructokinase |
|
|
|
31 |
L-Aspariginase |
Nitrilase (3-diazo-4-oxo-L-norvaline ® N2) |
|
|
|
32 |
A-Esterase |
Phosphotriesterase |
|
|
|
33 |
Carbonic anhydrase-III |
Esterase, phosphotriesterase, phospho monoesterase
(P-tyrosine preferred) |
|
|
|
34 |
Chymotrypsin |
Phosphotriesterase; acylation of own His57 (from
p-nitrobenzene sulfonate) |
|
|
|
35 |
Cytosine methyltransferase |
Cytosine deamination |
|
|
|
36 |
Myoglobin |
Sulfoxidation of thioanisole |
|
|
|
37 |
Pepsin A |
Phenyl sulfite hydrolysis |
|
|
|
38 |
Phytase (an acid phosphatase) |
Sulfoxidation (vanadate-dependent peroxidation
reaction) |
|
|
|
39 |
Serum
albumin (general binding protein) |
Esterase (p-nitophenyl acetate substrate) |
|
|
|
40 |
Urease |
Phosphoramidate hydrolysis |
|
|
|
41 |
Adenylate kinase |
Sulfuryl transfer from ADP-sulfate to acceptor |
|
|
|
42 |
Alkaline phosphatase |
Sulfatase; phosphodiesterase (substrates: sulfate and
phosphate esters of p-nitrophenol) |
|
|
|
43 |
Arylsulfatase A |
Cyclic phosphodiesterase (cAMP hydrolysis) |
|
|
|
44 |
Aspartate aminotransferase |
b-Elimination |
|
|
– sulfate from L-serine-O-sulfate |
|
|
– chloride from b-chloro-L-alanine |
|
|
– b-carboxyl group of
aspartate |
|
|
|
45 |
Pyruvate oxidase |
Acetohydroxy acid synthetase |
|
|
|
46 |
Chloroperoxidase (vanadium-dependent) |
Phosphomonoesterase (p-nitrophenyl phosphate
hydrolysis) |
|
|
|
47 |
RNA-binding enzymes7 |
|
|
– Catalase |
– own mRNA |
|
– Dihydrofolate reductase |
– own mRNA |
|
– Glutamate dehydrogenase |
– mRNA of cytochrome oxidase |
|
– Lactate dehydrogenase |
– homopolymeric RNA |
|
|
|
48 |
Lectin (V. faba seeds)8 |
a
-Galactosidase |
|
|
|
49 |
Non-histone protein BA9 |
Glutathione-S-transferase |
|
|
|
50 |
Apoprotein B-100 of LDL10 |
Phospholipase A2 |
|
|
|
51 |
H+-ATPase (reticulocyte
endosomes)11 |
Iron-binding protein |
|
|
|
52 |
G-protein bg-subunits
(HEK 293 cells)12 |
MAP
kinase activator |
|
|
|
53 |
DNAase (bovine pancreatic)13 |
Phosphatase (intrinsic; not phosphodiesterase) |
|
|
|
54 |
Lipoamide dehydrogenase (part of pyruvate dehydrogenase
complex-NAD specific)14 |
NADPH-ubiquinone reductase (Zn-acivated) |
|
|
|
55 |
Cytochrome P450 2C (coronary
arteries)15 |
Endothelium-dependent hyperpolarization factor (EDHF)
synthase |
|
|
|
56 |
Hemoglobin (ascaris)16 |
Nitric oxide activated dioxygenase |
|
|
Pooled information available on alternative
functions of some proteins: 1–14 from ref. 2; 15–30 from ref. 3;
31–45 from ref. 4 (original references are given in these three
reviews). |
probably time to consider developing a "protein
nomenclature" based on domain- level amino acid sequence, structu-ral
motifs and their arrangements in polypeptides. More and more proteins
will now be identified with multiple functions’.
The above article appeared to be well received in India
by the number of references to the simple, expressive (but not catchy,
colloquial) title ‘One protein – many functions’ that I
noticed in the meetings and private discussions. A modest number of
reprint requests came from several countries, not unusual in these days
of easy photocopying. This may reflect non-availability of the journal.
The first paragraph reproduced above was available in abstracting
services, and was accessed by a scientist in the UK while requesting the
reprint. Thus this information is readily available via the Internet to
the interested workers and journals. At the end of this article was
introduced a cartoon of Ravana with ten faces – a multifaceted
personality!
Is a protein having a second
function, a moonlighter?
An article entitled ‘Moonlighting proteins’ by
Jeffrey3 appeared in TIBS under the section ‘Talking
Points’. This article, with no reference to the two previous reviews on
the subject1,2, attracted my attention as it dealt with
multiple functions of proteins. The theme was similar in that a protein
can have more than one function as given in their introductory
paragraph: ‘cells have had to develop sophisticated mechanisms for
switching between the distinct functions of these proteins’. The author
clearly implied either/or type of action, made obvious by the example:
‘The aconitase/IRE-BP protein is either an enzyme or an RNA-binding
protein, not both simultaneously’. But there are many molecules of this
protein, some in mitochondrial matrix acting as aconitase and some in
the cytosol acting as IRE-BP. The two forms coexist, but in different
parts of the cell and function simultaneously2. The cartoon
in the TIBS article clearly shows the scientist doing different
jobs – inside the laboratory during the day and outside by
night. This seemed to have prompted the author to describe them as
‘moonlighting proteins’. I checked the dictionary for what ‘moonlighter’
means. The word was developed originally to describe ‘one of a band of
cowardly ruffians in Ireland in 1880 who committed agrarian outrages by
night’!
A mild protest letter was sent to the editor,
TIBS stating thus: ‘I am perplexed at the title . . .
certainly not the way to describe a protein having two or more
functions. The cell recruits such proteins for these multiple roles
deliberately . . . in the best interest of the economy of the
cell’. The editor promptly responded first by e-mail and then by a
letter: ‘moonlighting is a colloquial term for holding two
jobs – often (but not essentially) one of these at night. The
definition you have found in your dictionary has largely passed out of
common usage, at least in the UK. We try and check that colloquial words
and phrases as understood by our readers worldwide and obviously failed
this time’. Thanking him for the prompt response, I reiterated: "the
word used is unsuitable to describe the phenomenon. Different molecules
of the same polypeptide do the assigned multiple tasks – all
the time (not by day or night)’. Interestingly The Times
of India (Bangalore, 26 March 1999) published a story with
a cartoon on ‘a constable who moonlighted as a robber off duty’. The
newspaper cutting was sent to the editor, TIBS indicating that
‘Bangalore is fairly contemporary . . . . Indeed an
example is produced for a moonlighter’. The editor, forwarded my letter
and the reprint of the Current Science article to the
author, and after that I heard nothing. Authors tend to be silent in
such situations. Given a break in time, issues are silenced. Silence is
golden.
Is an enzyme having a second
catalytic activity, promiscuous?
Another article by O’Brien and Herschlag4
discussed ‘catalytic promiscuity of enzymes’. Again, the dictionary
defines the word, promiscuous, as ‘mixed, confused, indiscriminate, not
restricted to one’. But promiscuity is usually associated with ‘sexual
intercourse . . . without order or distinction’. (I dread the
follow-up words/synonyms – whore, pimp, lewd, harlot). What a
way to describe a ‘good’ protein serving the cell with multiple chores?
It almost implies the second activity (whichever it is) is undesirable.
This does not seem to be the intention of these authors, as they described the phenomenon from the limited viewpoint of
evolutionary acquisition of an additional activity by a protein ‘for
creation of new metabolic pathways from enzymes that were capable of
accepting a wide range of related substrates’. They introduced
‘catalytic promiscuity’ to describe ‘enzymes with an ability to catalyse
multiple chemical transformations that are normally classified as
different types of reactions’. In simple words, one
protein – many functions, described earlier2. But
this article did not benefit from the previous reviews on the
subject1–3, as none of them is found in their reference list.
They summarized the primary and the so-called ‘promiscuous’ activities
of several proteins in three tables: (1) ‘some active sites can catalyze
seeming disparate reactions’; (2) ‘enzymes . . . found to have
a low level of an alternative activity . . . of an
evolutionarily related enzyme’; (3) ‘examples of increased promiscuous
activity from protein engineering’. The theme developed by these authors
is that ‘catalytic promiscuity could have aided the evolution of new
enzymes via divergent evolution’.
The cell uses a polypeptide in
many ways
The three articles2–4 dealt with the theme
that a polypeptide can be used in more than one way in the cell. Trying
to draw the attention of readers, the authors3,4 have used
over-reaching personification of an enzyme protein that puts it in a bad
perspective. A passing reference to such names may tickle the reader but
continuing the appellation is unfair. Some damage is already done. A
recent report5 called the cell-junction forming protein,
pinin, a moonlighting protein (without acknowledging ref. 3) based
solely on its dual location in the cell! Restraint is needed by the
authors, and caution by the editors.
Information in these reviews on multiple functions of
some proteins is pooled and given in Table 1 along with some
additions.
One protein – many
aliases
Another dimension is added to the problem of naming a
protein: one protein-many aliases. Entitled ‘Wanted: A new order in
protein nomenclature’, the editorial in Nature (1999, 401,
411) pointed out that ‘A single protein is often studied simultaneously
by a number of independent laboratories, each using their own pet name
and refusing to acknowledge other names or agreeing to accept a single
label’. The protein, Eph B2 receptor, is an example. It has tyrosine
kinase activity and is involved in signalling in the brain. It is also
known by many aliases – Cek, Nek, Erk, Qek5, Tyro6, Sek3, Hek5
and Drt – according to species and tissues studied, and functions
identified by different workers. It is the same protein described from
many angles (remember the elephant and the blind men, with apology). The
Nature editorial pleaded for stating all other known names of a
protein for the first time it is mentioned in the text, and then proceed
to describe the function under study. A systemization of the protein
nomenclature is indeed wanted. In my article2, the question
of validity of the enzyme nomenclature was raised and a suggestion for
developing a ‘protein nomenclature’ was made. Perhaps this would be
realized soon.
New bugs in science
reporting
In the contemporary scene, scientists find it very
useful to have articles, such as trends, perspectives, hypotheses,
opinions, talking points and minireviews. These make it easy to
understand the racing developments in a particular field. These articles
require a good deal of reading and thought on the part of the writer.
They provide a ready means to understand some emerging phenomena. They
often enlighten the readers and enable relating these to their own work.
It is understandable such articles greatly influence readers, and earn
the journals high impact factors. A departure from simple, sober,
prosaic writing in science towards catchy titles, mind-boggling
appellations, attention-freezing illustrations and even slogan-worthy
dogmas has become trendy. Do we really need to emulate newspaper
reporting in science journals? In the wake of their high visibility,
there is also a lurking danger that some of them can mislead with
diversions into unproductive activities. Watch-out –colloquialism
is here.
- Kirschner, K. and Bisswanger, Annu. Rev.
Biochem., 1976, 45, 143–146.
- Ramasarma, T., Curr. Sci., 1994, 67,
24–29.
- Jeffery, C. J., Trends Biochem. Sci., 1999,
24, 8–11.
- O’Brien, P. J. and Herschlag, D., Chem. Biol., 1999,
6, R91–R105.
- Ouyang, P., Biochem. Biophys. Res.
Commun., 1999, 263, 192–200.
- Vasantha Rao, P., Horwitz, J. and Zigler Jr. J. S., J.
Biol. Chem., 1994, 269, 13266–13267.
- Hentze, M. W., Trends Biochem. Sci., 1994,
19, 101–102.
- Naiak, S. and Pridham, J. B., FEBS Lett., 1982,
150, 233–237.
- Bennet, C. F., Spector, D. L. and Yeoman, L. C., J.
Cell Biol., 1986, 102,
600–609.
- Parthasarathy, S. and Beinett, J., Proc. Nat.
Acad. Sci. USA, 1990, 87, 9741–9745.
- Li, C., Watkins, J, A., Hamazaki, S., Altazar, J. D. and Glass,
J., Biochemistry, 1995, 34, 5730–5736.
- Ito, J., Sato, T., Kaziro, Y. and Itoh, H., FEBS
Lett., 1995, 368, 183–187.
- Liao, T. H. and Hsieh, J. C., Biochem. J., 1998,
255, 781–787.
- Olsson, J. M., Xia, L., Erickson, L. C. and Bjornstedt, M.,
FEBS Lett., 1999, 448, 190–192.
- Fisslthaler, B., Popp, R., Kiss, L., Potente, M., Harder, D. R.,
Fleming, I. and Busse, R., Nature, 1999, 401, 493–497.
- Minning, D. M., Gow, A. J., Bonaventura, J., Baun, R., Dewhirst,
M., Goldberg, D. and Stamler, J. S., Nature, 1999, 401,
497–502.
T. Ramasarma is in the
Department of Biochemistry, Indian
Institute of Science, Bangalore
560 012,
India. |